PLATINUM SENSITIVE OVARIAN CANCER
Clinical trials for PLATINUM SENSITIVE OVARIAN CANCER explained in plain language.
Never miss a new study
Get alerted when new PLATINUM SENSITIVE OVARIAN CANCER trials appear
Sign up with your email to follow new studies for PLATINUM SENSITIVE OVARIAN CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Can surgery buy more time for women with returning ovarian cancer?
Disease control Not yet recruitingThis study looks at whether adding surgery after chemotherapy can help women with platinum-sensitive recurrent ovarian cancer live longer without their cancer growing. About 160 participants whose tumors shrank with chemo will be randomly assigned to get surgery plus more chemo o…
Matched conditions: PLATINUM SENSITIVE OVARIAN CANCER
Phase: PHASE2 • Sponsor: Asan Medical Center • Aim: Disease control
Last updated May 17, 2026 02:08 UTC
-
New hope for ovarian cancer: drug cocktail aims to control recurrence
Disease control Not yet recruitingThis study tests a new combination of drugs for women with ovarian cancer that has come back but still responds to platinum chemotherapy. The treatment includes an immunotherapy (iparomlimab/tuvonralimab) plus standard chemo, followed by a maintenance drug (olaparib). The goal is…
Matched conditions: PLATINUM SENSITIVE OVARIAN CANCER
Phase: PHASE2 • Sponsor: The First Affiliated Hospital of Soochow University • Aim: Disease control
Last updated May 17, 2026 02:06 UTC
-
New hope for ovarian cancer: could Rina-S outperform standard chemo?
Disease control Not yet recruitingThis study tests a new drug called Rina-S (with or without bevacizumab) against standard platinum-based chemotherapy for people with ovarian cancer that has come back but still responds to platinum treatments. About 688 participants will be randomly assigned to receive either the…
Matched conditions: PLATINUM SENSITIVE OVARIAN CANCER
Phase: PHASE3 • Sponsor: Genmab • Aim: Disease control
Last updated May 11, 2026 20:46 UTC